Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06MNW
|
||||
Former ID |
DNC004648
|
||||
Drug Name |
1-(oxazol-2-yl)octadec-9-en-1-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529594] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H35NO2
|
||||
Canonical SMILES |
CCCCCCCCC=CCCCCCCCC(=O)C1=NC=CO1
|
||||
InChI |
1S/C21H35NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21-22-18-19-24-21/h9-10,18-19H,2-8,11-17H2,1H3/b10-9-
|
||||
InChIKey |
WWYUNXGFLPTVRR-KTKRTIGZSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529594] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.